Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/8/16 → 04/7/18 |
Funding
- Boehringer Ingelheim Pharmaceutical: $6,500.00
A randomised, double-blind, placebo-controlled, paralled group, efficacy and saety study of empagliflozin (10 mg, 25 mg) administered orally, once daily over 24 weeks in hypertensive black/African American patients
- Dandona, Paresh (PI)
- Batra, Manav (CoI)
- Ghanim, Husam (CoI)
Project: Research